BFLY
Butterfly Network, Inc.NYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
5.30
P/S
10.72
EV/EBITDA
-13.60
DCF Value
$-3.95
FCF Yield
-1.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.9%
Operating Margin
-88.5%
Net Margin
-79.0%
ROE
-35.3%
ROA
-26.7%
ROIC
-36.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $31.5M | $-15.3M | $-0.06 |
| FY 2025 | $97.6M | $-77.1M | $-0.31 |
| Q3 2025 | $21.5M | $-34.0M | $-0.13 |
| Q2 2025 | $23.4M | $-13.8M | $-0.06 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
2.22
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smartphone, tablet, and hospital computer system; and Butterfly Blueprint, a system-wide ultrasound platform with Compass software that integrates into a healthcare system's clinical and administrative infrastructure. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as clinical support and services. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.